Maxim Group Maintains a Buy Rating on Actinium Pharmaceuticals (ATNM)

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Actinium Pharmaceuticals (NYSE: ATNM), with a price target of $3. The company’s shares opened today at $0.62. More »

Societe Generale Keeps a Hold Rating on Oracle Corp (ORCL)

Societe Generale analyst Richard Nguyen maintained a Hold rating on Oracle Corp (NYSE: ORCL) today and set a price target of $50. The company’s shares opened today at $48.23. Nguyen has an More »